Acurx Pharma Announces Stock Offering and Warrants to Support Growth Strategy

Apr 16, 2026

Acurx Pharmaceuticals has entered into a definitive agreement for the sale of 825,000 shares of common stock priced at $3.03 per share, alongside the issuance of short-term warrants covering up to 1.6 million additional shares. The warrants are immediately exercisable at $2.78 per share and carry a 24-month term.

The offering, expected to close in late April 2026, is subject to customary conditions and is aimed at supporting the company’s ongoing development of next-generation antibiotics for difficult-to-treat infections.

#AcurxPharmaceuticals
#Biotech
#StockOffering
#CapitalRaise
#Pharmaceuticals
#Antibiotics
#InfectiousDisease
#ClinicalTrials
#HealthcareInnovation
#DrugDevelopment
#BiotechInvesting
#Finance
#StockMarket
#JaneKing
#NewsOut